m6A-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with LUAD
2021 · Molecular Therapy — Nucleic Acids · 245 citations
https://doi.org/10.1016/j.omtn.2021.04.003
F
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
185
Papers
6.2K
Citations
40
h-index
90
i10-index
Feng Xu is an academic researcher from University of Science and Technology of China. The author has contributed to research in topics: RNA modifications and cancer & Asthma and respiratory diseases & Chronic Obstructive Pulmonary Disease (COPD) Research. The author has an h-index of 40, co-authored 158 publications.
ORCID: 0000-0001-6671-328XPapers by this author
worksSTING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production
2019 · Cell Reports · 96 citations
https://doi.org/10.1016/j.celrep.2019.09.069
Analysis of Lung Adenocarcinoma Subtypes Based on Immune Signatures Identifies Clinical Implications for Cancer Therapy
2020 · Molecular Therapy — Oncolytics · 86 citations
https://doi.org/10.1016/j.omto.2020.03.021
Hepatic mitochondrial transport of glutathione: Studies in isolated rat liver mitochondria and H4IIE rat hepatoma cells
2008 · Archives of Biochemistry and Biophysics · 62 citations
https://doi.org/10.1016/j.abb.2008.03.008
Prognostic Implication of a Metabolism-Associated Gene Signature in Lung Adenocarcinoma
2020 · Molecular Therapy — Oncolytics · 60 citations
https://doi.org/10.1016/j.omto.2020.09.011
Resistance elicited by sub-lethal concentrations of ampicillin is partially mediated by quorum sensing in Pseudomonas aeruginosa
2021 · Environment International · 31 citations
https://doi.org/10.1016/j.envint.2021.106619
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat